logo

Marinus Pharmaceuticals (MRNS)



Trade MRNS now with
  Date
  Headline
12/11/2018 4:04:25 PM Marinus Pharmaceuticals Announces Public Offering Of Common Stock
12/10/2018 7:36:21 AM Marinus Pharma Announces Positive Ganaxolone Data In Women With Postpartum Depression
12/4/2018 7:36:49 AM Marinus Pharma Says Ganaxolone Data From Its Phase 2 Clinical Trial At AES Annual Meeting
10/10/2018 7:32:04 AM Marinus Pharma Names Rolando Gutíerrez-Esteinou As VP Of Clinical Development And Pharmacovigilance
10/9/2018 4:51:01 PM Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
9/25/2018 7:32:12 AM Marinus Completes Enrollment In Its Magnolia Postpartum Depression Study
8/2/2018 7:42:04 AM Marinus Pharma Q2 Loss Per Share $0.24 Vs Loss $0.21 Last Year
6/19/2018 7:33:36 AM Marinus Pharma Initiates Pivotal Phase 3 Trial In Children With CDKL5 Deficiency Disorder
5/2/2018 7:33:38 AM Marinus Pharma Q1 Net Loss $6 Mln Vs Net Loss $5.4 Mln Last Year
12/14/2017 11:04:00 PM In The Spotlight: Marinus Pharma
10/31/2017 7:39:48 AM Marinus Pharmaceuticals Q3 Loss Per Share $0.15 Vs Loss $0.33 Prior Year